A study on usefulness and safety of donepezil for cognitive function and phychological symptoms of patients with Parkinson's disease and Alzheimer type dementia.

Trial Profile

A study on usefulness and safety of donepezil for cognitive function and phychological symptoms of patients with Parkinson's disease and Alzheimer type dementia.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 26 May 2017

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease; Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2017 Status changed from recruiting to discontinued.
    • 17 Dec 2013 Planned number of patients changed from 20 to 50 as reported by University Hospital Medical Information Network - Japan.
    • 22 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top